Cargando…
A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1
A serious limitation of numerous antitumor drugs is the incapacity to penetrate solid tumors. However, addition of an RGD fragment to peptide drugs might solve this problem. In this study, we explored whether the introduction of a permeability-enhancing sequence, such as iRGD (CRGDK/RGPD/EC) fragmen...
Autores principales: | Lao, Xingzhen, Liu, Meng, Chen, Jiao, Zheng, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747120/ https://www.ncbi.nlm.nih.gov/pubmed/23977262 http://dx.doi.org/10.1371/journal.pone.0072242 |
Ejemplares similares
-
Modified Thymosin Alpha 1 Distributes and Inhibits
the Growth of Lung Cancer in Vivo
por: Peng, Renhao, et al.
Publicado: (2020) -
Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life
por: Wang, Fanwen, et al.
Publicado: (2018) -
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer
por: Yang, Jie, et al.
Publicado: (2018) -
Novel 3D Structure Based Model for Activity Prediction and Design of Antimicrobial Peptides
por: Liu, Shicai, et al.
Publicado: (2018) -
Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells
por: Wang, Sheng, et al.
Publicado: (2023)